A. Unruh, A. Ressel, H. Mohamed, R. Johnson, R. Nadrowitz et al., The hypoxia-inducible factor-1?? is a negative factor for tumor therapy, Oncogene, vol.22, issue.21, pp.3213-3233, 2003.
DOI : 10.1038/sj.onc.1205047

D. Generali, A. Berruti, M. Brizzi, L. Campo, S. Bonardi et al., Hypoxia-Inducible Factor-1?? Expression Predicts a Poor Response to Primary Chemoendocrine Therapy and Disease-Free Survival in Primary Human Breast Cancer, Clinical Cancer Research, vol.12, issue.15, pp.4562-4570, 2006.
DOI : 10.1158/1078-0432.CCR-05-2690

P. Vaupel and A. Mayer, Hypoxia in cancer: significance and impact on clinical outcome, Cancer and Metastasis Reviews, vol.96, issue.4, pp.225-264, 2007.
DOI : 10.1016/j.ijrobp.2006.07.1376

G. Semenza, HIF-1 and tumor progression: pathophysiology and therapeutics, Trends in Molecular Medicine, vol.8, issue.4, pp.62-703, 2002.
DOI : 10.1016/S1471-4914(02)02317-1

K. Binley, Z. Askham, L. Martin, H. Spearman, D. Day et al., Hypoxia-mediated tumour targeting, Gene Therapy, vol.95, issue.7, pp.540-549, 2003.
DOI : 10.1073/pnas.95.5.2509
URL : http://www.nature.com/gt/journal/v10/n7/pdf/3301944a.pdf

C. Sotiriou and M. Piccart, Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?, Nature Reviews Cancer, vol.97, issue.7, pp.545-53, 2007.
DOI : 10.1200/JCO.2005.04.7985

J. Chi, Z. Wang, D. Nuyten, E. Rodriguez, M. Schaner et al., Gene Expression Programs in Response to Hypoxia: Cell Type Specificity and Prognostic Significance in Human Cancers, PLoS Medicine, vol.8, issue.3, pp.47-16417408, 2006.
DOI : 10.1371/journal.pmed.0030047.st002

E. Rankin and A. Giaccia, The role of hypoxia-inducible factors in tumorigenesis, Cell Death and Differentiation, vol.61, issue.4, pp.678-85, 2008.
DOI : 10.1172/JCI30269

Y. Tsai and K. Wu, Hypoxia-regulated target genes implicated in tumor metastasis, Journal of Biomedical Science, vol.19, issue.1, p.23241400, 2012.
DOI : 10.1261/rna.027615.111
URL : https://jbiomedsci.biomedcentral.com/track/pdf/10.1186/1423-0127-19-102?site=jbiomedsci.biomedcentral.com

D. Gilkes and G. Semenza, Role of hypoxia-inducible factors in breast cancer metastasis, Future Oncology, vol.65, issue.11, pp.1623-1659, 2013.
DOI : 10.1242/dev.083881

H. Rundqvist and R. Johnson, Tumour oxygenation: implications for breast cancer prognosis, Journal of Internal Medicine, vol.167, issue.2, pp.105-117, 2013.
DOI : 10.1083/jcb.200408130
URL : http://onlinelibrary.wiley.com/doi/10.1111/joim.12091/pdf

R. Bos, P. Van-der-groep, A. Greijer, A. Shvarts, S. Meijer et al., Levels of hypoxia-inducible factor-1? independently predict prognosis in patients with lymph node negative breast carcinoma, Cancer, vol.5, issue.6, pp.1573-81, 2003.
DOI : 10.1002/cncr.11246

R. Campbell, P. Bhat-nakshatri, N. Patel, D. Constantinidou, S. Ali et al., Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance, J Biol Chem, vol.27615, issue.1301, pp.9817-9841, 2001.

A. Mangia, A. Chiriatti, A. Bellizzi, A. Malfettone, B. Stea et al., Biological role of NHERF1 protein expression in breast cancer, Histopathology, vol.5, issue.5, pp.600-608, 2009.
DOI : 10.1016/S0002-9440(10)63944-2

S. Shenolikar, J. Voltz, R. Cunningham, and E. Weinman, Regulation of Ion Transport by the NHERF Family of PDZ Proteins, Physiology, vol.19, issue.6, pp.362-371, 2004.
DOI : 10.1152/physiol.00020.2004

R. Cardone, A. Bellizzi, G. Busco, E. Weinman, M. Dell-'aquila et al., The NHERF1 PDZ2 Domain Regulates PKA-RhoA-p38-mediated NHE1 Activation and Invasion in Breast Tumor Cells, Molecular Biology of the Cell, vol.18, issue.5, pp.1768-80, 2007.
DOI : 10.1091/mbc.E06-07-0617

E. Metzen, D. Stiehl, K. Doege, J. Marxsen, T. Hellwig-burgel et al., ) gene: identification of a functional hypoxia-responsive element, Biochemical Journal, vol.387, issue.3, pp.711-718, 2004.
DOI : 10.1042/BJ20041736

J. Marxsen, P. Stengel, K. Doege, P. Heikkinen, T. Jokilehto et al., Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases, Biochem J, vol.38124, pp.761-768, 2004.

A. Couvelard, L. Deschamps, V. Rebours, A. Sauvanet, K. Gatter et al., Overexpression of the Oxygen Sensors PHD-1, PHD-2, PHD-3, and FIH Is Associated with Tumor Aggressiveness in Pancreatic Endocrine Tumors, Clinical Cancer Research, vol.14, issue.20, pp.6634-6643, 2008.
DOI : 10.1158/1078-0432.CCR-07-5258

N. Denko and . Hypoxia, Hypoxia, HIF1 and glucose metabolism in the solid tumour, Nature Reviews Cancer, vol.554, issue.9, pp.705-718, 2008.
DOI : 10.4161/cc.5.8.2681

G. Semenza, B. Jiang, S. Leung, R. Passantino, J. Concordet et al., Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1, Journal of Biological Chemistry, vol.55, issue.51, pp.32529-32566, 1996.
DOI : 10.1016/S0022-2828(95)91407-2

D. Zhang, L. Tai, L. Wong, L. Chiu, S. Sethi et al., -positive Breast Cancer*, Molecular & Cellular Proteomics, vol.7, issue.11, pp.1686-96, 2005.
DOI : 10.1111/j.1349-7006.2003.tb01345.x

P. Sonveaux, F. Vegran, T. Schroeder, M. Wergin, J. Verrax et al., Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice, Journal of Clinical Investigation, vol.11827, issue.1211, pp.3930-3972, 2008.
DOI : 10.1172/JCI36843DS1
URL : http://www.jci.org/articles/view/36843/files/pdf

Z. Wang, T. Loo, J. Shen, N. Wang, D. Wang et al., LDH-A silencing suppresses breast cancer tumorigenicity through induction of oxidative stress mediated mitochondrial pathway apoptosis, Breast Cancer Research and Treatment, vol.86, issue.1???2, p.1, 2011.
DOI : 10.1139/O07-156

K. Moritz, G. Lim, and E. Wintour, Developmental regulation of erythropoietin and erythropoiesis, Am J Physiol. Pt, vol.27322, issue.2, pp.1829-1873, 1997.

P. Maxwell, C. Pugh, and P. Ratcliffe, Inducible operation of the erythropoietin 3' enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism., Proceedings of the National Academy of Sciences, vol.90, issue.6, pp.2423-2430, 1993.
DOI : 10.1073/pnas.90.6.2423

B. Ebert and H. Bunn, Regulation of the erythropoietin gene, Blood, vol.94, issue.6, pp.1864-77, 1999.

G. Acs, M. Chen, X. Xu, P. Acs, A. Verma et al., Autocrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cells, Cancer Letters, vol.214, issue.2, pp.243-51, 2004.
DOI : 10.1016/j.canlet.2004.04.027

D. Wojchowski, R. Gregory, C. Miller, A. Pandit, and T. Pircher, Signal transduction in the erythropoietin receptor system, Exp Cell Res. Epub, vol.25312, issue.1, pp.143-56, 1999.

Y. Miura, O. Miura, J. Ihle, and N. Aoki, Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor, J Biol Chem. Epub, vol.26925, issue.4711, pp.29962-29971, 1994.

A. Anagnostou, Z. Liu, M. Steiner, K. Chin, E. Lee et al., Erythropoietin receptor mRNA expression in human endothelial cells., Proceedings of the National Academy of Sciences, vol.91, issue.9, pp.3974-3982, 1994.
DOI : 10.1073/pnas.91.9.3974
URL : http://www.pnas.org/content/91/9/3974.full.pdf

K. Liang, S. Qiu, Y. Lu, and Z. Fan, Autocrine/paracrine erythropoietin regulates migration and invasion potential and the stemness of human breast cancer cells, Cancer Biology & Therapy, vol.269, issue.1, pp.89-98, 2014.
DOI : 10.1007/s10911-012-9255-3

M. Oikawa, M. Abe, H. Kurosawa, W. Hida, K. Shirato et al., Hypoxia Induces Transcription Factor ETS-1 via the Activity of Hypoxia-Inducible Factor-1, Biochemical and Biophysical Research Communications, vol.289, issue.1, pp.39-43, 2001.
DOI : 10.1006/bbrc.2001.5927